Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis

Main Article Content

Caitriona Ryan
Alan Menter
Lyn Guenther
Andrew Blauvelt
Robert Bissonnette
Fan E Yang
Allison P Bleakman
David A Amato


genital psoriasis, ixekinumab, biologic therapy


Abstract not Available.


Disclosures: Study sponsored by Eli Lilly.


Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>